Choose an Ailment
Alcoholism ALS Alzheimer’s Disease Anorexia Anxiety Disorders Arthritis Asthma Autism Back Pain Bladder Cancer Brain Cancer Breast Cancer Cerebral Palsy Chronic Pain Chronic Stress Colon Cancer COPD
Crohn's Disease Depression Diabetes Disc Degeneration Epilepsy & Seizures Fibromyalgia Glaucoma Heart Disease HIV / AIDS Huntington’s Disease Leukemia Liver Disease Lung Cancer Lupus Malaria Migraines Multiple Sclerosis
Latest Ailment Research
Study: Cannabinoids vs. Chronic Neuropathic Pain
A systematic review published in the Journal of Oral & Facial Pain and Headache found cannabis to be effective in managing chronic neuropathic pain.
Cannabinoid Treatments vs Triple-Negative Breast Cancer
Studies suggest THC and CBD, the main cannabinoids found in medical marijuana, may help fight and protect against different forms of breast cancer.
Cannabis-Based Treatments For Multiple Sclerosis
Learn About Effective Cannabis-Based Medicines For Medical Marijuana Patients Living With Multiple Sclerosis
THC May Help Protect Against Neurodegenerative Diseases
Recent studies show low doses of THC can help treat inflammation in the brain from neurodegenerative diseases like Alzheimer’s and Parkinson’s.
Cannabinoids Show Potential In Reducing Nausea
A recent Canadian study showed cannabinoids (specifically THCV and CBDV) aided in reducing nausea when treated in 10-20mg doses.
Study: Cannabidiol as an Effective Asthma Treatment
Researchers at Brazil’s Universidade do Extremo Sul Catarinense conducted a study examining how CBD may effectively manage asthma symptoms in mice.
An Overview Of Alzheimer's Studies with Cannabis
Studies have shown that medical marijuana may help treat certain alzheimer's symptoms, but doing so must be done with caution.
Study Shows CBD May Effectively Treat Colon Cancer
In recent studies cannabis extracts high in cannabidiol (CBD) were shown to help prevent the genesis and spread of colon cancer in subjects.
Cannabidiol (CBD) May Weaken Lung Cancer Cells
German study shows CBD can enhance the susceptibility of lung cancer cells to adhere to and be broken down by lymphokine-activated killer (LAK) cells.